Welcome
Welcome to the UEG Week Medfyle Conference Coverage. In this website you will find a digested selection of hot topics and key data from the 2022 UEG Week. Watch the video introduction from our Editor, and explore the other content available.
Interviews
Watch the interviews with some of the international experts who contributed to the UEG Week 2022.
Recent advances in the diagnosis and management of early alcohol-related liver disease: And where to go next?
12
How common is alcohol-related liver disease?
80
Are our perceptions of this disease changing?
146
Traditionally, has there been a delay in diagnosing alcohol-related liver disease?
177
How does this impact outcomes and treatment choices?
229
Will early management change the picture?
Fistulising CD: Assess, treat, error
12
How common are fistulas in Crohn’s disease?
56
How does fistula location change morbidity and mortality?
110
What assessments and evaluations are needed?
183
How has classification evolved with modern imaging techniques?
226
What are the fundamentals of management?
What's new in gastroenterology?
12
How has research into inflammation changed our understanding of gastroenterology?
57
How has the treatment landscape changed as a result?
100
What new techniques are particularly exciting in gastroenterology?
156
Can you tell us a little bit about your current research?
223
What hot topics do you cover in your UEGW presentation?
What's new in hepatology?
12
How has research in recent years changed the field of hepatology?
59
Has this changed the treatment landscape?
99
What new techniques are particularly exciting in hepatology?
128
Can you tell us a little bit about your current research?
146
What hot topics do you cover in your UEGW presentation?
Faecal microbiota transplant: An essential tool to explore microbiome host interactions
12
How does the gut microbiome impact health?
69
What biochemical functions does the microbiome perform for the host?
150
What is a faecal microbiota transplant?
245
What’s the science underpinning this approach?
309
What diseases could this kind of transplant treat?
Complications in end-stage NAFLD
12
How common is NAFLD?
54
What are the most common extra-hepatic complications?
86
Is there routine screening for these complications?
156
How do complications in change in end-stage disease?
197
Can we identify patients who are at risk for these complications?
Incidential pancreatic cyst: Lifelong follow up for small cysts or molecular markers for risk stratification?
12
How common are incidential pancreatic cysts?
105
How has the clinical presentation of pancreatic cysts evolved in recent years?
151
What is the malignancy risk with incidential pancreatic cysts?
243
Are there biomarkers we can use from cyst aspirates?
298
How can this information be used for risk stratification?
Deep Dives
Deep Dive: Inflammatory Bowel Disease
Want to learn more about the latest IBD data? Watch the interviews and presentations on these conditions.
What’s new in Ulcerative Colitis?
New therapies in Crohn’s disease
Assessing ulcerative colitis and evolving UC clinical remission goals
Advances and long term outcomes in Ulcerative Colitis
Ulcerative colitis treatments
Upcoming next best therapeutic option for IBD
The LUCENT-1 induction trial
Addressing fatigue in Crohn’s disease
Summaries
Missed the full presentation? Read at-a-glance summaries from a selection of oral presentations presented this year. Don’t forget to download the slide kits!
Posters
Browse and download a selection of posters presented this year.
